Insights

Technology is advancing at a remarkable pace. Can regulatory agencies keep up? They are working hard at that and in that process come many changes. The line between what is a consumer device and what is a...

Surgical robotics will have a prosperous short-term future, with most key players expected to introduce laparoscopic surgical robotic systems by 2020. By 2030, the convergence of several technology opportunities, including...

Real-time nitrate sensing holds the potential for significant yield increases, cost savings, and environmental impact reduction. 

Year on year we’re producing more and more waste electronics – e-waste. Recovering the valuable materials embedded in e-waste will become significantly more important. At present this is a highly manual process...

Thanks to AI and smart algorithms combined with low cost sensors, giving legacy system 'smarts' is an effective way in delivering a multitude of benefits.

Clinical trials are vital for informing pharmaceutical companies about drug action and efficacy, and for demonstrating the safety of new drugs. However, they can be notoriously expensive, time-consuming to conduct, and the commercial...

It’s that CES time of year again and alongside the latest technology and product launches, I think 2019 will be the year we see much greater use of tech for insights and trials.

Cambridge Consultants recently brought together some of the brightest names and biggest companies in the medical device industry, to explore how surgical navigation can democratize surgery in the future and to envision the surgical navigation ecosystem of 2030.

The application of technology in the food and beverage industry is growing in four areas – Automation, Sustainability, Personalisation and Experience design.

The recent launch of the Apple Watch Series 4 is the latest example of a device developed by a traditional consumer product company making a well-publicized entry into the patient-facing medical device market. Patient-facing devices...

Apple just released the software to enable taking a home ECG on the Watch 4. I tried it out! Will this impact our health?

Many of the dominant pharmaceutical companies operate partly, or wholly, in the generic drugs market. In 2016, the generics divisions of Teva, Mylan and Novartis all reported revenues in excess of $9bn with the top ten manufacturers...